Duration
18 months
Cost
Free to Patients
Phase
Phase III
Closes
Dec 2025
Comparing a structured low-carbohydrate eating plan to standard dietary guidelines for blood sugar management.
Patient Advocacy Endorsed
This trial has been reviewed and endorsed by American Diabetes Association. PAG endorsement means patient advocates have evaluated the trial design, risk-benefit profile, and patient-friendliness of this study.
Trial Summary
Eli Lilly UAE
Head-to-head comparison of tirzepatide and insulin glargine in UAE adults with poorly controlled T2D.
NCT05401245
Dexcom
Assessing whether continuous glucose monitoring improves outcomes and reduces hypoglycemia in elderly T2D patients.
NCT05198765